Dermoscopy Certification Course Accreditation
Activity Overview
Participants will learn to differentiate benign nevi from early acral melanoma, identify high-risk features requiring
biopsy or referral, and recognize mimickers such as hemorrhage or traumatic pigmentation. Case-based questions
and evidence-based insights will guide learners toward improved diagnostic confidence and patient outcomes in both
primary and specialty care settings.
Target Audience
This activity is designed for an audience of Physicians, Nurses, Nurse Practitioner, Physician Assistants.
Learning Objectives
Upon completion of the educational activity, participants should be able to:
- Differentiate the dermoscopic patterns characteristic of benign versus malignant lesions on volar and acral skin.
- Recognize the significance of the parallel ridge pattern as a hallmark feature of acral melanoma.
- Identify the typical presentations of benign acral nevi, including the parallel furrow and fibrillar patterns.
- Distinguish acral hemorrhage from melanocytic lesions using dermoscopic clues such as color, border, and pattern.
- Describe the dermoscopic features associated with congenital volar nevi and the “peas in a pod” pattern.
Criteria for Success
To obtain a certificate of completion, a score of 80% or better on the post-test is required. Please proceed with the activity until
you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have
received a digital copy of your certificate. You must participate in the entire activity to receive credit. There is no fee to
participate in this activity. If you have questions about this activity, please contact AKH Inc. at byron@akhcme.com.
AKH Inc., Advancing Knowledge in Healthcare
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and BCI Management and Communications. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this enduring material for a maximum of 7.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
Credit being awarded: 7.50 ANCC contact hours.
Physician Associate
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician
Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME
Criteria. This activity is designated for 7.50 AAPA Category 1 CME credits. Approval is valid until . PAs should
only claim credit commensurate with the extent of their participation.
Nurse Practitioners
This activity has been planned and implemented in accordance with the
Accreditation Standards of the American Association of Nurse Practitioners (AANP)
through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and
BCI Management and Communications. AKH Inc., Advancing Knowledge in
Healthcare is accredited by the American Association of Nurse Practitioners as an
approved provider of nurse practitioner continuing education. Provider number:
030803. This activity is approved for 7.50 contact hours.
Commercial Support
There is no commercial support for this activity.
Disclosures
| Name | Relationship | Commercial Interest |
|---|---|---|
| Richard Usatine, MD (faculty) | N/A | Nothing to disclose |
| Tracey Vlahovic, DPM (faculty) | Advisor | Ortho Dermatologics |
| Risha Bellomo, PA (faculty/planner) | N/A | Nothing to disclose |
| Dorothy Caputo, MA, BSN, RN – VP, Healthcare Continuing Education and Operations | N/A | Nothing to disclose |
| Bernadette Makar, MSN, APRN-BC, NP-C (planner/reviewer) | N/A | Nothing to disclose |
| Michele Bielarski, RN (planner/reviewer) | N/A | Nothing to disclose |
| AKH Inc Staff and Planners | N/A | Nothing to disclose |
| BCI Management and Communication Staff and Planners | N/A | Nothing to disclose |
All of the relevant financial relationships listed for these individuals have been mitigated.
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing
education activities. The author must disclose to the participants any significant relationships with ineligible companies whose
products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity.
Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no
relevant financial relationships to disclose.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to optout@akhcme.com with your information with “Opt Out” in the subject line.